Status | Study |
Recruiting |
Study Name: A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study) Condition: Chronic Myeloid Leukemia Date: 2014-02-28 Interventions: Drug: Omacetaxine mepesuccinate 3.5 mg omacetaxine mepesuccinate and 10 mg mannitol; The first dose of t |
Recruiting |
Study Name: Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia Condition: Chronic Phase Chronic Myeloid Leukemia Accelerated Phase Chronic Myelo Date: 2013-07-28 Interventions: Drug: Nilotinib Nilotinib dose |
Recruiting |
Study Name: Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myel Date: 2013-04-22 Interventions: Biological: therapeutic allogeneic lymphocytes |
Completed |
Study Name: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myel Date: 2013-02-07 Interventions: Drug: vorinostat Given PO |
Recruiting |
Study Name: Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymp Date: 2013-01-02 Interventions: Drug: Fludarabine phosphate Gi |
Withdrawn |
Study Name: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Le Date: 2012-07-20 Interventions: Drug: cyclophosphamide Given I |
Active, not recruiting |
Study Name: Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymp Date: 2012-04-26 Interventions: Biological: tetanus-CMV fusion peptide vaccine |
Withdrawn |
Study Name: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymp Date: 2012-03-16 Interventions: Procedure: management of therapy complications |
Active, not recruiting |
Study Name: Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymp Date: 2012-02-06 Interventions: Drug: fludarabine phosphate Gi |
Terminated |
Study Name: Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants Condition: Acute Leukemia in Remission Myelodysplastic Syndromes Leuk Date: 2011-11-20 Interventions: Drug: Sirolimus Sirolimus will |